CPRX is a buy! Good P/E Ratio with a good growth profile. Stock is down because of the lawsuit which is not really a true competition.
Chart self explanatory #undervalued #LEMS #CMS #CPP109
nice looking set up on this bio play. watching for a move over 5 $XBI $CPRX
Catalyst Pharmaceutical (CPRX) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to loss of $0.01 per share a year ago. wait for a decent retracement and buy.
Dates in the future with the highest probability for price direction reversals
Firdapse Spinal Muscular Atrophy (SMA) Type 3 **** Phase 2 data due 1H 2020 Firdapse MuSK-antibody positive myasthenia gravis (MuSK-MG) **** Phase 3 data due 1H 2020 Short Float = 13.23% Broke out of triangle, looking for a small pullback to the cloud / support line, have a stop under suport line at 4.20 and Target at 7.50 for at possible 70% upside...
Buyers have come into market breakout the upper trend line backed by volume to form a bullish wedge breakout
Buyers have broken upper trend line with increase volume forming a bullish wedge trend line breakout
I forgot what this strategy was called. Please let me know in the comment.
Looks like a decent setup, but possibly early and unpredictable. Dec or Jan calls are cheap enough for a tiny position.
Buy and sell opportunity: wait for a bullish and bearish reversal in buy and sell zones respectively. Trend analysis: Monthly - up Weekly - up Daily - down (correction) Hourly - down Long-term opportunity: buy Short-term opportunity: sell
The setup on the weekly chart looks quite good with price now reaching an area of supportive confluence. I anticipate price support is found on the trendline and fibs where high R-multiple long setups can be constructed. If we decline further I am watching $4.50 and $4.31 (0.618 fib) for a strong bounce. The news this week is immaterial to CPRX's valuation,...
Now that the bullish trend broke after failed CMS trials, target the next support region between Target $3-3.50
With a confluence of strong fundamentals and technical setup CPRX should see $8.60 as a first medium term price target, a 50% price increase from closing price on 10/25/19. Long term CPRX has the potential to go materially higher than first price target based on fundamentals and sell-side consensus.